Stuart Collinson – Aurora Biosciences Corporation (absc)
STUART J.M. COLLINSON serves as Chairman, CEO and President of Aurora
Biosciences Corporation. He joined Aurora in May 1999 as President, was
appointed Chief Executive Officer and a member of the Board of Directors
in November 1999 and in March 2000 was appointed as Aurora's Chairman of
the Board. Under his leadership, the company has raised over $75 million
in private financing, grown to over 400 employees, and formed a number
of significant collaborations including those with American Home
Products, Cystic Fibrosis Foundation, GlaxoSmithKline, Merck and Pfizer.
Before joining Aurora, Dr. Collinson served as Chief Executive Officer
of Andaris Ltd., a privately held biopharmaceutical company in the UK.
He held senior management positions at Glaxo Wellcome and Baxter
International Inc., and was a consultant with The Boston Consulting
Group. Dr. Collinson received an MBA from Harvard Business School and a
PhD in Physical Chemistry from the University of Oxford. Profile
TWST: Could we begin with a brief historical sketch of Aurora
Biosciences Corporation and then an overview?
Dr. Collinson: Aurora Biosciences was founded in 1995 by two scientists